|Bid||4.3700 x 1000|
|Ask||4.4400 x 29200|
|Day's Range||3.9399 - 4.4300|
|52 Week Range||3.7050 - 8.4000|
|Beta (3Y Monthly)||4.74|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CEO Interviews with: HEXO, HOTH, MDCL, NEXCFNews & VIDEO from Investor Conferences: NEXCF, MDCL NEW YORK, Sept. 18, 2019 -- Wall Street Reporter, the trusted name in.
The award recognizes professional cannabis growers whose dedication to their craft consistently produces top quality crops for the marketplace. The nominees are growers that set the bar for others to match.
Award-winning Helios dried flower now available to Ontarians GATINEAU, Quebec, Aug. 14, 2019 -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) is pleased to.
NYSE: HEXO) cannabis products are now available to Alberta consumers for the first time after finalizing an agreement between HEXO and Alberta Gaming, Liquor and Cannabis (AGLC). The agreement provides AGLC with HEXO’s nine dried flower products and award-winning Elixir oral sprays, making them available on the Alberta Cannabis online store and to all of the nearly 200 private retail stores in the province.
Looking for big upside? This group of explosive penny stocks, including HEXO Corp (TSX:HEXO)(NYSE:HEXO), might provide the pop you're looking for.
NYSE: HEXO) announces that HEXO co-founder, Adam Miron, has decided to step down from his position as Chief Brand Officer. Adam Miron co-founded HEXO six years ago with Sebastien St-Louis and has played a key role not only in building the company, but as an innovative leader in the cannabis industry.
NYSE-A: HEXO) is pleased to announce it has received approval from the New York Stock Exchange (the “NYSE”) to transfer the listing of its common shares from the NYSE American LLC (the “NYSE-A”) to the NYSE. HEXO expects to begin trading on the NYSE effective at the open of markets on July 16, 2019.
A HEXO Corp.’s executive expects his company’s cannabis beverages joint venture with Molson Coors Brewing Company will be a “springboard” for a global drinks expansion.
The Canadian cannabis producer delivered sizzling year-over-year revenue growth in its third quarter thanks to adult-use sales. However, its limited production capacity remained an issue.
NYSE-A: HEXO) is pleased to announce that its affiliate, HEXO MED S.A. (“HEXO MED”) has received a medical cannabis installation license. The license, issued by the Greek government, will allow HEXO MED to establish cultivation, processing and manufacturing facilities in the region of Thessaly, Greece. With HEXO Corp’s experience in the industry, HEXO MED is poised to become a leader in the European cannabis landscape.
Key highlights of third quarter of 2019 fiscal year HEXO remains on-track ramping up to $400 million net revenue in fiscal 2020 and to double net revenue in Q4 fiscal.